Search details
1.
Hematologic malignancies following immune checkpoint inhibition for solid tumors.
Cancer Immunol Immunother
; 72(1): 249-255, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-35691988
2.
Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial.
Lancet Oncol
; 23(6): 818-828, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35654052
3.
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study.
Lancet
; 398(10306): 1157-1169, 2021 09 25.
Article
in English
| MEDLINE | ID: mdl-34508654
4.
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Haematologica
; 105(12): 2805-2812, 2020 12 01.
Article
in English
| MEDLINE | ID: mdl-33256379
5.
Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study.
Mycoses
; 62(12): 1140-1147, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-31520441
6.
Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients.
Br J Haematol
; 183(1): 60-67, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30080247
7.
Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia.
Blood
; 137(8): 1117-1120, 2021 02 25.
Article
in English
| MEDLINE | ID: mdl-33027809
8.
Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA.
J Hematol Oncol
; 16(1): 104, 2023 09 14.
Article
in English
| MEDLINE | ID: mdl-37705050
9.
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.
Blood Cancer J
; 13(1): 85, 2023 05 22.
Article
in English
| MEDLINE | ID: mdl-37217463
10.
Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group.
Leuk Lymphoma
; 63(10): 2276-2289, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35737364
11.
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia.
Clin Cancer Res
; 28(5): 870-881, 2022 Mar 01.
Article
in English
| MEDLINE | ID: mdl-34862243
12.
Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach.
Cancers (Basel)
; 14(8)2022 Apr 07.
Article
in English
| MEDLINE | ID: mdl-35454765
13.
(89) Zr-rituximab PET/CT to detect neurolymphomatosis.
Am J Hematol
; 91(6): 649-50, 2016 06.
Article
in English
| MEDLINE | ID: mdl-26872558
14.
Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study.
Blood Adv
; 5(15): 2958-2964, 2021 08 10.
Article
in English
| MEDLINE | ID: mdl-34338755
15.
Changes in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib.
Leuk Lymphoma
; 61(14): 3422-3431, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32865439
16.
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.
Nat Commun
; 11(1): 1044, 2020 02 25.
Article
in English
| MEDLINE | ID: mdl-32098966
17.
Clinical Practice Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia (CLL) in The Netherlands.
Clin Lymphoma Myeloma Leuk
; 18(1): 52-57, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29097160
18.
Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia.
Leuk Lymphoma
; 50(5): 788-801, 2009 May.
Article
in English
| MEDLINE | ID: mdl-19452318
19.
Adequate synapse formation between leukemic B cells and effector T cells following stimulation with artificial TCR ligands.
Leuk Lymphoma
; 49(8): 1592-602, 2008 Aug.
Article
in English
| MEDLINE | ID: mdl-18766973
20.
VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration.
Am J Physiol Cell Physiol
; 285(2): C343-52, 2003 Aug.
Article
in English
| MEDLINE | ID: mdl-12700137
Results
1 -
20
de 20
1
Next >
>>